United States · FDA National Drug Code directory
TIGLUTIK
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 11797-210_2ba33fab-05a6-42db-9b4a-277bb3a30f29
- Product NDC
- 11797-210
- Form
- SUSPENSION
- Composition / generic term
- Riluzole
- Labeler
- Italfarmaco SPA
- Marketing category
- NDA
- Marketing start / end (source format)
- 20180921
- Source listing expiry
- 20271231
Source-listed ingredients
- RILUZOLE — 50 mg/10mL
These values do not establish equivalence or a dose recommendation.
Packages
- 2 BOTTLE, PLASTIC in 1 CARTON (11797-210-01) / 300 mL in 1 BOTTLE, PLASTIC · 11797-210-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →